ABArgante Bozzi

Argante Bozzi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Argante Bozzi has a total of 234 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Apoptotic effects of bovine apo‐lactoferrin on HeLa tumor cells

    by Carla Luzi, Fabrizia Brisdelli, Roberto Iorio, Argante Bozzi, Veronica Carnicelli, Antonio Di Giulio, Anna Rita Lizzi

    Lactoferrin (Lf), a cationic iron‐binding glycoprotein of 80 kDa present in body secretions, is known as a compound with marked antimicrobial activity. In the present study, the apoptotic effect of iron‐free bovine lactoferrin (apo‐bLf) on human epithelial cancer (HeLa) cells was examined in association with reactive oxygen species and glutathione (GSH) levels. Apoptotic effect of iron‐free bovine lactoferrin inhibited the growth of HeLa cells after 48 hours of treatment while the diferric‐bLf was ineffective in the concentration range tested (from 1 to 12.5 μM). Western blot analysis showed that key apoptotic regulators including Bax, Bcl‐2, Sirt1, Mcl‐1, and PARP‐1 were modulated by 1.25 μM of apo‐bLf. In the same cell line, apo‐bLf induced apoptosis together with poly (ADP‐ribose) polymerase cleavage, caspase activation, and a significant drop of NAD+. In addition, apo‐bLf–treated HeLa cells showed a marked increase of reactive oxygen species level and a significant GSH depletion. On the whole, apo‐bLf triggered apoptosis of HeLa cells upon oxygen radicals burst and GSH decrease.


  • Protolichesterinic acid enhances doxorubicin-induced apoptosis in HeLa cells in vitro

    by Fabrizia Brisdelli, Mariagrazia Perilli, Doriana Sellitri, Pierangelo Bellio, Argante Bozzi, Gianfranco Amicosante, Marcello Nicoletti, Marisa Piovano, Giuseppe Celenza


  • Folding propensity of anoplin: A molecular dynamics study of the native peptide and four mutated isoforms

    by Massimiliano Aschi, Carla Luzi, Annarita Fiorillo, Argante Bozzi

    Anoplin, a cationic decapeptide amide GLLKRIKTLL‐NH2 derived from venom sac of the solitary wasp Anoplius samariensis has been investigated through Molecular Dynamics. The wild‐type (WT) and four isoforms were simulated both in water and in the membrane‐mimicking solvent trifluoroethanol (TFE). In water all the investigated species, found to be in rapid equilibrium between different conformational states, can be considered as unfolded. On the other hand, in TFE all the systems enhance their rigidity and, in general, show α‐helix as the main folded conformation. Interestingly, a semi‐quantitative thermodynamic analysis has suggested that the folding driving force is not always the same being in some cases (e.g., the WT Anoplin) of entropic nature and in other cases of energetic nature. © 2015 Wiley Periodicals, Inc. Biopolymers 103: 692–701, 2015.


  • Open Access

    Effects of azidothymidine on protein kinase C activity and expression in erythroleukemic cell K562 and acute lymphoblastic leukemia cell HSB-2

    by Veronica Carnicelli, Anna Rita Lizzi, Giancaterino Gualtieri, Argante Bozzi, Nicola Franceschini, Antonio Di Giulio

    Azidothymidine (AZT) is one of the anti-retroviral drugs currently used for the treatment of HIV-infected patients. Several other effects of the drug have been studied in vitro, such as the alterations of some enzymes, the inhibition of cell proliferation, and the increase of transferrin receptor expression. In this study, we investigated the alterations of protein kinase C (PKC) activity, PKCα and PKCβII expressions and plasmatic membrane fluidity induced by AZT in two cancer cell lines, human chronic myeloid (K562) and human acute lymphoblastic (HSB-2) leukemia cells, respectively. The results showed that both PKC activity and membrane fluidity in HSB-2 cells increased after 24 h of drug incubation. PKCα expression in HSB-2 cells decreased after 48 h of AZT exposure, when the cell growth also decreased. However, in K562 cells, the PKCα and PKCβII expressions enhanced in the presence of the drug when the growth was inhibited. The results indicate that AZT is less effective in inhibiting the growth of acute lymphoblastic HSB-2 leukemia cells than inhibiting that of chronic myeloid K562 cells. In fact, after 24 h exposure, the HSB-2 cell growth decreased less than K562 cell growth.

  • ELF-MF attenuates quercetin-induced apoptosis in K562 cells through modulating the expression of Bcl-2 family proteins

    by Fabrizia Brisdelli, Francesca Bennato, Argante Bozzi, Benedetta Cinque, Fabrizio Mancini, Roberto Iorio

    This study investigated the effects of sinusoidal ELF-MF (1 mT; 50 Hz) on the apoptosis induced by four different compounds, namely vinblastine, etoposide, quercetin, and resveratrol, in human K562 chronic myeloid leukemia cells. The exposure to ELF-MF did not affect growth and viability of untreated K562 cells and did not influence the anti-proliferative effects of resveratrol, vinblastine, and etoposide. On the contrary, in quercetin-treated cells, exposure to ELF-MF significantly reduced the percentage of apoptotic cells and the caspase-3 activity and modified the cell cycle profile especially after 48 h of exposure. In addition, the simultaneous treatments for 24 h with quercetin plus ELF-MF increased Bcl-2 protein expression and prevented quercetin-induced downregulation of Mcl-1 and Bcl-xL. Finally, an increase of HSP70 expression was also observed after prolonged ELF-MF treatment. The ELF-MF-dependent modulation of the expression of anti-apoptotic Bcl-2 family and Hsp70 proteins could act as a pro-survival mechanism in K562 cells.


  • P‐113 Peptide: New experimental evidences on its biological activity and conformational insights from molecular dynamics simulations

    by Alessia Di Giampaolo, Carla Luzi, Bruno Casciaro, Argante Bozzi, Maria Luisa Mangoni, Massimiliano Aschi

    In this article, we report novel and additional results, both experimental and computational, obtained in our laboratories on the peptide P-113. In particular, our experimental results indicate that this peptide is endowed with a high target-cell selectivity towards yeast species, suggesting its potential development as a new drug against oral microbial infections. To provide additional structural insights, we performed several Molecular Dynamics simulations in different conditions. Results suggest that P-113 is a rather compact species presumably because of its highly charged state as emerged from the dramatic increase of internal fluctuation occurring upon point-mutation. The peptide turns out to adopt, in water, a beta-hairpin-like conformation and, in a more hydrophobic environment, is found to be in a (probably slow) equilibrium between α-helix and hairpin conformations. Complexation with Zn2+ induces a drastic mechanical stabilization, which prevents any conformational organization of the peptide into a biologically active state. © 2013 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 102: 159–167, 2014.


  • Open Access

    pH‐dependent disruption of Escherichia coli ATCC 25922 and model membranes by the human antimicrobial peptides hepcidin 20 and 25

    by Giuseppantonio Maisetta, Alberto Vitali, Mariano A. Scorciapino, Andrea C. Rinaldi, Raffaele Petruzzelli, Franca L. Brancatisano, Semih Esin, Annarita Stringaro, Marisa Colone, Carla Luzi, et al.

    The human hepcidin 25 (hep‐25) and its isoform hepcidin 20 (hep‐20) are histidine‐containing, cystein rich, β‐sheet structured peptides endowed with antimicrobial activity. We previously reported that, similar to other histidine‐containing peptides, the microbicidal effects of hep‐25 and hep‐20 are highly enhanced at acidic pH. In the present study, we investigated whether pH influences the mode of action of hep‐25 and hep‐20 on Escherichia coli American Type Culture Collection 25922 and model membranes. A striking release of β‐galactosidase by hepcidin‐treated E. coli was observed at pH 5.0, whereas no inner membrane permeabilization capacity was seen at pH 7.4, even at bactericidal concentrations. Similar results were obtained by flow cytometry when assessing the internalization of propidium iodide by hepcidin‐treated E. coli. Scanning electron microscope imaging revealed that both peptides induced the formation of numerous blebs on the surface of bacterial cells at acidic pH but not at neutral pH. Moreover, a phospholipid/polydiacetylene colourimetric vesicle assay revealed a more evident membrane damaging effect at pH 5.0 than at pH 7.4. The leakage of entrapped dextrans of increasing molecular size from liposomes was also assessed at pH 7.4. Consistent with the lack of β‐galactosidase release from whole E. coli observed at such a pH value, evident leakage of only the smallest 4‐kDa dextran (and not of dextrans of 20 or 70 kDa) was observed, indicating a poor ability of hepcidin peptides to permeabilize liposome vesicles at pH 7.4. Altogether, the data obtained in the present study using different approaches strongly suggest that the ability of hepcidins to perturb bacterial membranes is markedly pH‐dependent.


  • Structural and dynamical properties of KTS‐disintegrins: A comparison between Obtustatin and Lebestatin

    by Isabella Daidone, Massimiliano Aschi, Maria Patamia, Argante Bozzi, Raffaele Petruzzelli

    Obtustatin and Lebestatin are lysine‐threonine‐serine (KTS)‐disintegrins, which are a family of low molecular weight polypeptides present in many viperidae venoms and are potent and specific inhibitors of collagen‐binding integrins. The integrin binding loop, harboring the 21KTS23 motif, and the C‐terminal tail are known to be responsible for the selective binding to the α1β1 integrin. Despite a very high sequence homology (only two mutations are present in Lebestatin relative to Obtustatin, namely R24L and S38L), Lebestatin exhibits a higher inhibitory effect than Obtustatin on cell adhesion and cell migration to collagens I and IV. Here we show, by means of molecular dynamics simulations of the two polypeptides in aqueous solution, that Lebestatin possesses a higher flexibility of the C‐terminal tail and a greater solvent accessibility of the integrin binding loop than Obtustatin. It may be hypothesized that these properties may contribute to the higher binding‐affinity of Lebestatin to its biological partner.


  • Cytotoxic Activity and Antioxidant Capacity of Purified Lichen Metabolites: An In Vitro Study

    by Fabrizia Brisdelli, Mariagrazia Perilli, Doriana Sellitri, Marisa Piovano, Juan A. Garbarino, Marcello Nicoletti, Argante Bozzi, Gianfranco Amicosante, Giuseppe Celenza

    The purpose of this study was to investigate the effects of six lichen metabolites (diffractaic acid, lobaric acid, usnic acid, vicanicin, variolaric acid, protolichesterinic acid) on proliferation, viability and reactive oxygen species (ROS) level towards three human cancer cell lines, MCF‐7 (breast adenocarcinoma), HeLa (cervix adenocarcinoma) and HCT‐116 (colon carcinoma). Cells were treated with different concentrations (2.5–100 μM) of these compounds for 48 h. In this comparative study, our lichen metabolites showed various cytotoxic effects in a concentration‐dependent manner, and usnic acid was the most potent cytotoxic agent, while variolaric acid did not inhibit the proliferation of any of the three cell lines used. All tested lichen compounds did not exhibit free radical scavenging activity using the 1,1‐diphenyl‐2‐picrylhydrazyl (DPPH) assay. The lichen metabolites did not significantly increase the intracellular ROS level and did not prevent oxidative injury induced by t‐butylhydroperoxide in HeLa cells. To better clarify the mechanism(s) of cytotoxic effect induced by protolichesterinic acid in HeLa cells, we investigated apoptotic markers such as condensation and fragmentation of nuclear chromatin and activation of caspase‐3, 8 and 9. Our results revealed that the antiproliferative activity of 40 μM protolichesterinic acid in HeLa cells is related to its ability to induce programmed cell death involving caspase‐3, 8 and 9 activation. Copyright © 2012 John Wiley & Sons, Ltd.


  • Differential Phosphoproteome Analysis of K562 Cells Exposed to 3-Azido- 3-Deoxythymidine (AZT)

    by Gabriele D'ANdrea, Sara Venditti, Laura Di Francesco, Valerio Bernabei, M. Eugenia Schinina, Argante Bozzi

    By means of ELISA, confocal microscopy, FACS, 2-DE, ImageJ software, MALDI-ToF-MS, and PMF, in this study we report the differentially phosphoproteins expressed in untreated as well as in AZT-treated K562 cells. As evidenced by ELISA, and partly confirmed by confocal microscopy and flow cytometry analysis, an overall increase in Ophosphorylation was found in the AZT-treated samples. Additional analyses allowed to identify 17 spots representing 10 phosphoproteins differentially expressed, proteins which are involved in many significant biological functions such as mRNA processing, assembly and/or transport of ribosome, protein folding, energetic metabolism, cytoskeleton motility, growth control, hypoxia tolerance, allergic and stress responses. Five out of 10 phosphoproteins were up-regulated in K562 cells previously exposed to 20 μM AZT for 3 h (i.e. calreticulin, stathmin, triosephosphate isomerase, stressinduced- phosphoprotein-1, peptidyl-prolyl cis-trans isomerase A). On the contrary, the other five phosphoproteins were down-regulated (i.e. nucleophosmin, lactoylglutathione lyase, 3-hydroxyacyl-CoA dehydrogenase type-2, heterogeneous nuclear ribonucleoproteins A2-B1, alpha-enolase). The proteins identified in the present study represent the first clear report of differential phosphoproteins expression upon AZT treatment of human chronic myeloid leukemia (K562) cells. Therefore, this type of proteomic analysis could be envisaged as a further tool useful for monitoring response(s) to the drug, like the toxic side effects observed in HIV-infected patients under AZT therapy.